The FDA's assessment of the bread recall has designated it as a Class II risk, which means the product "may cause temporary ...

Sarepta Therapeutics is pausing shipments of its gene therapy for muscular dystrophy following several patient deaths that ...

Confused about hair transplant vs hair restoration? Learn the key differences, benefits, and which option might be right for ...

Novo Nordisk holds 72% international and 50%+ U.S. market share in GLP-1 treatments, serving 46 million patients globally.

Replimune shares collapsed on Tuesday after the U.S. Food and Drug Administration rejected the clinical-stage biotechnology company's proposed advanced melanoma treatment. Shares of the Woburn, Mass., ...

Sarepta Therapeutics reversed course and agreed to halt all shipments of Elevidys, its gene therapy for Duchenne muscular ...

President Trump says Coca-Cola will swap out high-fructose corn syrup with cane sugar. Here’s what research says about its ...

A brief skirmish between Sarepta Therapeutics and the FDA has ended before escalating into a full-on regulatory clash, as the company has bowed to the agency’s demand. | A brief skirmish between ...

Initiating Rapid Micro Biosystems at 'buy' with $4.60 fair value, driven by strong growth potential in automated microbial ...

Pennsylvania-based A.P. Deauville, LLC is recalling several types of its Power Stick deodorant, due to a process issue.

Each year, choking claims the lives of more than 4,100 Americans who are 65 or older. It’s the most vulnerable age group, ...

Shares of Sarepta Therapeutics fell nearly 7% on Tuesday after the company agreed to comply with the U.S. health regulator's request to pause all shipments of its gene therapy Elevidys in the United ...